NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…
Net proceeds will be applied to debt reduction, advancing Organon’s ongoing deleveraging efforts Positions Organon for future investment in growth…
Enrolling patients in ongoing randomized Phase 1b trial in MSS metastatic colorectal cancer, evaluating TTX-080 in combination with cetuximab +…
King of Prussia, Pennsylvania--(Newsfile Corp. - November 7, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company…
The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, AI detection, and precision oncology under one…
SYDNEY, Nov. 6, 2025 /PRNewswire/ -- Lumonus, a leader in AI powered radiation oncology workflow solutions, today announced the close…
WASHINGTON, Nov. 6, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people…
Reinvestment from existing backers underscores confidence in Elephas' predictive approach to improving immunotherapy treatment response rates MADISON, Wis., Nov. 6,…
The leading voice on longevity health shares a science-based, proactive approach to staying strong, sharp, and independent SAN FRANCISCO, Nov. 6,…
NEW YORK, Nov. 6, 2025 /PRNewswire/ -- Hone Health, the leader in longevity intelligence and personalized care, is teaming up with…